Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XXX, No. 13 - September 11, 2023

IVD Consolidation Reduces Choices for Labs

Since the launch of The Dark Report in 1995, consolidation of hospitals, physician groups, clinical labs, pathology groups, and IVD manufacturers has been a major trend every year. Today, that consolidation has handed unprecedented economic power to the nation’s two multi-billion-dollar lab corporations and to the IVD manufacturers who sell them automation, analyzers, and tests. …

IVD Consolidation Reduces Choices for Labs Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

Is Lab and IVD Consolidation Ready to Hit the Wall?

IN HUMAN HISTORY, ALL ERAS COME TO AN END. The majority of the time, the end of an era is disruptive and a new status quo emerges, with different winners and losers. Today, there is growing evidence that one era in clinical laboratory testing and IVD manufacturing may be close to ending. We present our …

Is Lab and IVD Consolidation Ready to Hit the Wall? Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

No Surprises Act Sparks a Slew of Court Decisions

CEO SUMMARY: Multiple lawsuits filed by the Texas Medical Association against the federal government have resulted in key decisions that affect provisions in the law. Qualifying payment amounts and resolution processes are key areas of disagreement between the opposing sides. Pathologists and clinical labs will be affected by the final outcomes of these court challenges. …

No Surprises Act Sparks a Slew of Court Decisions Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

IVD and Lab Consolidation Reduces Choices for Labs

CEO SUMMARY: Since the launch of The Dark Report in 1995, consolidation of hospitals, physician groups, clinical labs, pathology groups, and IVD manufacturers has been a major trend every year. Today, that consolidation has handed unprecedented economic power to the nation’s two multi-billion-dollar lab corporations and to the IVD manufacturers who sell them automation, analyzers, …

IVD and Lab Consolidation Reduces Choices for Labs Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

Don’t Automate Bad Work Processes in Microbiology

CEO SUMMARY: Automation is not always right for every lab’s microbiology department, according to consultants from bioMérieux. When evaluating automated instruments, it is necessary to review work flow and manual processes in microbiology to identify inefficiencies. Once those are addressed, automation may be a logical next step. IT’S OFTEN ASSUMED BY CLINICAL LABORATORY LEADERS in …

Don’t Automate Bad Work Processes in Microbiology Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

Lab Data Crucial to Insurer Risk Adjustment Models

CEO SUMMARY: Payers who use risk adjustment models as part of Medicare Advantage need diagnostic data that helps them document ICD-10 diagnoses that earn them higher premium payments for sicker patients. Clinical labs have lab test data that can identify undiagnosed disease and share in the higher risk-adjusted payments. IN TRANSITIONING FROM FEE-FOR-SERVICE MODELS TO …

Lab Data Crucial to Insurer Risk Adjustment Models Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

Private Health Insurers Are Aware of Problems with CPT Code 81408

EDITOR’S NOTE: Our column, Virchow, is written by anonymous insiders working within the managed care world. The column aims to help clients of The Dark Report better understand the decisions, policies, and actions of payers as they manage their laboratory networks, establish coverage guidelines, process lab test claims, and audit labs. RECENTLY, THE DARK REPORT …

Private Health Insurers Are Aware of Problems with CPT Code 81408 Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

UHC Will Delay Enforcement of Z-codes for Genetic Test Claims

IN THE LATEST BACKPEDAL ON ITS NEW POLICY, UNITEDHEALTHCARE (UHC) appears to have dropped its requirement for genetic testing laboratories to use Z-codes for claims under commercial health plans—for now. Earlier, we reported that the enforcement date had moved from Aug. 1 to Oct. 1. Since then, the payer has changed language in its guidance …

UHC Will Delay Enforcement of Z-codes for Genetic Test Claims Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

Lab News Briefs: Joint Commission, Bon Secours, Anthem, Walmart

Joint Commission Looks at Cyberattacks The Joint Commission issued a Sentinel Event Alert for hospitals to address cyberattacks. The alert prominently mentions clinical labortory concerns. The alert notes that laboratory systems and other critical technology could be down for four weeks or longer following a cyberattack. “Ensuring access to medical history/results and making sure laboratory, …

Lab News Briefs: Joint Commission, Bon Secours, Anthem, Walmart Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

September 11, 2023, Intelligence: Late-Breaking Lab News

Here’s another twist in the saga of Theranos, the defunct and discredited lab testing company. Consumers who received inaccurate results from Theranos’ blood tests may get some measure of justice. Walgreens Boots Alliance agreed to settle a class action lawsuit with these consumers for $44 million, Bloomberg reported on Sept. 7. The proposal, which needs …

September 11, 2023, Intelligence: Late-Breaking Lab News Read More »

To read the full article, members can click here to log in.  Not a member yet? 
Please click here to sign up for your free two-week trial to The Dark Report.

;